Tailored Exercise Rehabilitation with Pacing
Treatment for Long COVID
Typical Dosage: Very low intensity, short durations, gradual increase based on individual tolerance and strict pacing
Effectiveness
55%
Safety Score
85%
Clinical Trials
12
Participants
1.2K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
85
DangerousModerateSafe
Treatment Details
Dosage Range
Very low intensity, short durations, gradual increase based on individual tolerance and strict pacing
Time to Effect
1-3 months
Treatment Duration
6-12 months initially, ongoing for maintenance
Evidence Quality
MODERATEConfidence Score
60%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,000
Side Effect Mgmt:$0
Total Annual:$1,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
0.13
Outcome-Based Costs
Cost per Responder
$2,000
Tailored Exercise Rehabilitation with Pacing Outcomes
for Long COVID
Efficacy Outcomes
Overall Effectiveness
+55%
Response Rate
+50%
Remission Rate
+8%
Common Side Effects
Post-Exertional Malaise (PEM) if overdone
+25%
Fatigue
+12%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov